COMMUNIQUÉS West-GlobeNewswire

Ovid Therapeutics to Present at Two Investor Healthcare Conferences in October 2018

19/09/2018 - 15:05

NEW YORK, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]

Nexstim Plc to Present Depression Led Strategy at Investor Conference Sijoittaja 2018 in Helsinki

19/09/2018 - 15:01

Press release, Helsinki, 19 th September 2018 at 4:00 PM EEST Nexstim Plc to Present Depression Led Strategy at Investor Conference Sijoittaja 2018 in Helsinki Nexstim Plc to host a Conference Call / Webcast on Tuesday [...]

BioStem Technologies Inc. to Present at The MicroCap Conference on October 1st and 2nd in New York City at the Essex House

19/09/2018 - 15:00

Pompano Beach, FL, Sept. 19, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a concentration [...]

Aduro Biotech Announces the Departure of Natalie R. Sacks, M.D.

19/09/2018 - 15:00

BERKELEY, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that Natalie R. Sacks, M.D. has resigned from her position as the company’s chief medical officer effective October [...]

Genmab to Host Capital Markets Day

19/09/2018 - 14:59

Media Release Review of Genmab’s progress and operations Event will take place at Genmab’s R&D Center in Utrecht, the Netherlands Event will be webcast live with an archived version available Copenhagen, Denmark; [...]

Bravo’s Wellness Strategy Team Expands

19/09/2018 - 14:54

CLEVELAND, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Bravo announces the addition of Deanna Wolfe to its growing wellness strategy team. Wolfe joins Bravo from Limeade, where she worked directly with top customers using data [...]

Eyenovia to Participate in Panel Presentation at OSN New York 2018

19/09/2018 - 14:30

CEO Sean Ianchulev to join industry panel discussion on “Medical and Surgical Management of Corneal Conditions and Complications” NEW YORK, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a [...]

Zosano Pharma Completes Manufacture of M207 Registration Batches

19/09/2018 - 14:30

FREMONT, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of [...]

Achaogen Announces Multiple Plazomicin Presentations at IDWeek 2018

19/09/2018 - 14:01

SOUTH SAN FRANCISCO, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing, and commercializing innovative antibacterials addressing multi-drug [...]

Spero Therapeutics to Present at the Cantor Global Healthcare Conference in October

19/09/2018 - 14:00

CAMBRIDGE, Mass., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments [...]

BioSig Technologies to Commence Trading on the Nasdaq

19/09/2018 - 14:00

Trading to Begin on the Nasdaq Capital Market on September 21, 2018 Santa Monica, CA, Sept. 19, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. ( OTCQB:BSGM, OTCQB:BSGMD ), a medical device company developing a [...]

Soleno Therapeutics to Participate in Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease

19/09/2018 - 14:00

REDWOOD CITY, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today [...]

Cynata’s Cymerus™ MSCs Ameliorate Cytokine Release Syndrome in Preclinical Study

19/09/2018 - 14:00

• Cymerus MSCs demonstrate substantial protection against CRS symptoms, a serious adverse reaction caused by cancer immunotherapies such as CAR-T MELBOURNE, Australia, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Australian stem [...]

Molecular Templates Announces Agreement with Takeda for the Joint Development of a Protein-Based Oncology Therapy

19/09/2018 - 14:00

The Agreement Will Support the Development of a Potential New Treatment Option for Multiple Myeloma AUSTIN, Texas, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq:MTEM) today announced an agreement [...]

Scilex Announces Pricing and Availability of ZTlido™ for the Commercial Launch of its First Product in October of 2018

19/09/2018 - 14:00

SAN DIEGO, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Scilex Pharmaceuticals Inc. (Scilex), a subsidiary of Sorrento Therapeutics, Inc. (NASDAQ: SRNE) (Sorrento), today announced that the Wholesale Acquisition Cost (WAC) for [...]

AIT Therapeutics Presented Nitric Oxide Data at the European Respiratory Society International Congress 2018

19/09/2018 - 14:00

GARDEN CITY, N.Y. and REHOVOT, Israel, Sept. 19, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ( [...]

The American Health Council Welcomes Hartmuth B. Bittner, MD, Ph.D., FACS to its Board of Physicians

19/09/2018 - 14:00

NEW YORK, Sept. 19, 2018 (GLOBE NEWSWIRE) -- The American Health Council welcomes Hartmuth B. Bittner, MD, Ph.D., FACS to its Board of Physicians for his outstanding contributions to the medical field. Dr. Bittner [...]

North Bud Farms to Begin Trading on the Canadian Securities Exchange

19/09/2018 - 14:00

TORONTO, Sept. 19, 2018 (GLOBE NEWSWIRE) -- North Bud Farms Inc . (" NORTHBUD " or the " Company ") is pleased to announce that its common shares will commence trading on the Canadian Securities Exchange (“ CSE ”) at [...]

Conatus Pharmaceuticals to Participate in Upcoming Investor Conferences

19/09/2018 - 13:30

SAN DIEGO, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) has accepted invitations to participate in two upcoming investor conferences. At the Oppenheimer Fall Summit Focused on Specialty [...]